Skip to main content
. 2011 Apr;22(4):782–790. doi: 10.1681/ASN.2010070691

Table 3.

Risk of stroke, sudden death, MI, death caused by CHF, combined CVEs, and all-cause mortality per unit increase in copeptin (continuous variable, log-transformed)

Outcome HR and 95% CI
Crude Adjusted Adjusteda
Stroke 1.73 1.74 1.62
(1.25 to 2.39) (1.23 to 2.47) (1.11 to 2.36)
P < 0.001 P = 0.002 P = 0.012
Sudden death 1.49 1.44 1.33
(1.16 to 1.92) (1.10 to 1.91) (0.99 to 1.80)
P = 0.002 P = 0.009 P = 0.059
MI 1.05 1.00 0.99
(0.85 to 1.30) (0.79 to 1.25) (0.77 to 1.26)
P = 0.627 P = 0.964 P = 0.90
Death caused by CHF 1.53 1.33 1.37
(0.93 to 2.53) (0.75 to 2.36) (0.74 to 2.55)
P = 0.098 P = 0.332 P = 0.323
Combined CVEb 1.32 1.24 1.18
(1.14 to 1.52) (1.06 to 1.45) (1.00 to 1.40)
P < 0.001 P = 0.008 P = 0.052
All-cause death 1.30 1.29 1.18
(1.15 to 1.50) (1.12 to 1.48) (1.02 to 1.36)
<0.001 P < 0.001 P = 0.032

aFurther adjustment for markers of volume status and residual urine output.

bMI, cardiac death, and stroke.